Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-028788

Director sold 13,000 shares at an average $46.28 ($601,615)

From the SEC's structured data for this filing

Trades in this filing

GANNON STEVEN · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-07 Sale : show line 1 in the form −1,000 $46.45 $46,450 14,000 D
2024-03-07 Sale : show line 2 in the form −5,000 $46.25 $231,250 9,000 D
2024-03-07 Sale : show line 3 in the form −5,000 $46.30 $231,513 4,000 D
2024-03-07 Sale : show line 4 in the form −2,000 $46.20 $92,402 2,000 D
Open-market sales · 13,000 sh · avg $46.28 · $601,615
Loading xslF345X05/ownership.xml…